{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:48:20Z","timestamp":1790812100990,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T00:00:00Z","timestamp":1491350400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s13577-017-0169-7","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T14:05:37Z","timestamp":1491401137000},"page":"209-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Ramelteon, a selective MT1\/MT2 receptor agonist, suppresses the proliferation and invasiveness of endometrial cancer cells"],"prefix":"10.1007","volume":"30","author":[{"given":"Kiyono","family":"Osanai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8474-0625","authenticated-orcid":false,"given":"Yoichi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Otsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutoshi","family":"Iwashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,5]]},"reference":[{"key":"169_CR1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10654-015-0017-6","volume":"30","author":"D Schmid","year":"2015","unstructured":"Schmid D, Behrens G, Keimling M, Jochem C, Ricci C, Leitzmann M. A systematic review and meta-analysis of physical activity and endometrial cancer risk. Eur J Epidemiol. 2015;30:397\u2013412.","journal-title":"Eur J Epidemiol"},{"key":"169_CR2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1034\/j.1600-079X.2000.280405.x","volume":"28","author":"Y Kanishi","year":"2000","unstructured":"Kanishi Y, Kobayashi Y, Noda S, Ishizuka B, Saito K. Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines. J Pineal Res. 2000;28:227\u201333.","journal-title":"J Pineal Res"},{"key":"169_CR3","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.2174\/092986710794183015","volume":"17","author":"MD Mediavilla","year":"2010","unstructured":"Mediavilla MD, Sanchez-Barcelo EJ, Tan DX, Manchester L, Reiter RJ. Basic mechanisms involved in the anti-cancer effects of melatonin. Curr Med Chem. 2010;17:4462\u201381.","journal-title":"Curr Med Chem"},{"key":"169_CR4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-079X.1991.tb00007.x","volume":"10","author":"S Cos","year":"1991","unstructured":"Cos S, Blask DE, Lemus-Wilson A, Hill AB. Effects of melatonin on the cell cycle kinetics and \u201cestrogen-rescue\u201d of MCF-7 human breast cancer cells in culture. J Pineal Res. 1991;10:36\u201342.","journal-title":"J Pineal Res"},{"key":"169_CR5","first-page":"4383","volume":"58","author":"S Cos","year":"1998","unstructured":"Cos S, Fern\u00e1ndez R, G\u00fc\u00e9zmes A, S\u00e1nchez-Barcel\u00f3 EJ. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res. 1998;58:4383\u201390.","journal-title":"Cancer Res"},{"key":"169_CR6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000009926","volume":"45","author":"W Grin","year":"1998","unstructured":"Grin W, Gr\u00fcnberger W. A significant correlation between melatonin deficiency and endometrial cancer. Gynecol Obstet Invest. 1998;45:62\u20135.","journal-title":"Gynecol Obstet Invest"},{"key":"169_CR7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuropharm.2004.09.007","volume":"48","author":"K Kato","year":"2005","unstructured":"Kato K, Hirai K, Nishiyama K, et al. Neurochemical properties of ramelteon (TAK-375), a selective MT1\/MT2 receptor agonist. Neuropharmacology. 2005;48:301\u201310.","journal-title":"Neuropharmacology"},{"key":"169_CR8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1755-5949.2008.00066.x","volume":"15","author":"M Miyamoto","year":"2009","unstructured":"Miyamoto M. Pharmacology of ramelteon, a selective MT1\/MT2 receptor agonist: a novel therapeutic drug for sleep disorders. CNS Neurosci Ther. 2009;15:32\u201351.","journal-title":"CNS Neurosci Ther"},{"key":"169_CR9","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mc.20832","volume":"51","author":"J Le\u00f3n","year":"2012","unstructured":"Le\u00f3n J, Casado J, Carazo A, et al. Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer. Mol Carcinog. 2012;51:608\u201318.","journal-title":"Mol Carcinog"},{"key":"169_CR10","first-page":"339","volume":"22","author":"J Fujimoto","year":"2001","unstructured":"Fujimoto J, Sakaguchi H, Aoki I, Toyoki H, Khatun S, Tamaya T. Inhibitory effect of ginsenoside-Rb2 on invasiveness of uterine endometrial cancer cells to the basement membrane. Eur J Gynaecol Oncol. 2001;22:339\u201341.","journal-title":"Eur J Gynaecol Oncol"},{"key":"169_CR11","unstructured":"Takeda Pharmaceuticals America, Inc. Drug interview form: Rozerem\u00ae tablets 8\u00a0mg. 2010. https:\/\/www.takedamed.com\/mcm\/medicine\/download.jsp?id=144&type=INTERVIEW_FORM . Accessed Jul 2010."},{"key":"169_CR12","unstructured":"Takeda Pharmaceuticals America, Inc. Highlight of prescribing information: Rozerem. 2005. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/021782s011lbl.pdf ."},{"key":"169_CR13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1600-079X.2007.00470.x","volume":"43","author":"T Kokkola","year":"2007","unstructured":"Kokkola T, Vaittinen M, Laitinen JT. Inverse agonist exposure enhances ligand binding and G protein activation of the human MT1 melatonin receptor, but leads to receptor down-regulation. J Pineal Res. 2007;43:255\u201362.","journal-title":"J Pineal Res"},{"key":"169_CR14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ygyno.2003.12.038","volume":"93","author":"S Oreskovic","year":"2004","unstructured":"Oreskovic S, Babic D, Kalafatic D, Barisic D, Beketic-Oreskovic L. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma. Gynecol Oncol. 2004;93:34\u201340.","journal-title":"Gynecol Oncol"},{"key":"169_CR15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1439-0434.2002.00691_2.x-i1","volume":"35","author":"Y Kobayashi","year":"2003","unstructured":"Kobayashi Y, Itoh MT, Kondo H, et al. Melatonin binding sites in estrogen receptor-positive cells derived from human endometrial cancer. J Pineal Res. 2003;35:71\u20134.","journal-title":"J Pineal Res"},{"key":"169_CR16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1447-0756.2008.00818.x","volume":"34","author":"M Watanabe","year":"2008","unstructured":"Watanabe M, Kobayashi Y, Takahashi N, Kiguchi K, Ishizuka B. Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line. J Obstet Gynaecol Res. 2008;34:567\u201373.","journal-title":"J Obstet Gynaecol Res."},{"key":"169_CR17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cdp.2006.03.002","volume":"30","author":"S Cos","year":"2006","unstructured":"Cos S, Gonz\u00e1lez A, Mart\u00ednez-Campa C, Mediavilla MD, Alonso-Gonz\u00e1lez C, S\u00e1nchez-Barcel\u00f3 EJ. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions. Cancer Detect Prev. 2006;30:118\u201328.","journal-title":"Cancer Detect Prev"},{"key":"169_CR18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/1534735409353332","volume":"8","author":"SM Hill","year":"2009","unstructured":"Hill SM, Frasch T, Xiang S, Yuan L, Duplessis T, Mao L. Molecular mechanisms of melatonin anticancer effects. Integr Cancer Ther. 2009;8:337\u201346.","journal-title":"Integr Cancer Ther."},{"key":"169_CR19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-079X.2004.00207.x","volume":"38","author":"EJ S\u00e1nchez-Barcel\u00f3","year":"2005","unstructured":"S\u00e1nchez-Barcel\u00f3 EJ, Cos S, Mediavilla D, Mart\u00ednez-Campa C, Gonz\u00e1lez A, Alonso-Gonz\u00e1lez C. Melatonin\u2013estrogen interactions in breast cancer. J Pineal Res. 2005;38:217\u201322.","journal-title":"J Pineal Res"},{"key":"169_CR20","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/cncr.10355","volume":"94","author":"LA Nezza Di","year":"2002","unstructured":"Di Nezza LA, Misajon A, Zhang J, et al. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinases expression with increasing tumor grade and invasion. Cancer. 2002;94:1466\u201375.","journal-title":"Cancer"},{"key":"169_CR21","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/bcr2794","volume":"12","author":"L Mao","year":"2010","unstructured":"Mao L, Yuan L, Slakey LM, Jones FE, Burow ME, Hill SM. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway. Breast Cancer Res. 2010;12:R107.","journal-title":"Breast Cancer Res"},{"key":"169_CR22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/jpi.12032","volume":"54","author":"K Jablonska","year":"2013","unstructured":"Jablonska K, Pula B, Zemla A, et al. Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma. J Pineal Res. 2013;54:334\u201345.","journal-title":"J Pineal Res"},{"key":"169_CR23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1172\/JCI78782","volume":"125","author":"K Yumimoto","year":"2015","unstructured":"Yumimoto K, Akiyoshi S, Ueo H, et al. F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner. J Clin Invest. 2015;125:621\u201335.","journal-title":"J Clin Invest."},{"key":"169_CR24","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/cas.12236","volume":"104","author":"T Wada","year":"2013","unstructured":"Wada T, Ishimoto T, Seishima R, et al. Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia. Cancer Sci. 2013;104:1323\u20139.","journal-title":"Cancer Sci"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13577-017-0169-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-017-0169-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-017-0169-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:52:34Z","timestamp":1601859154000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13577-017-0169-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["169"],"URL":"https:\/\/doi.org\/10.1007\/s13577-017-0169-7","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,5]]}}}